BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31212368)

  • 1. Establishing a cryopreservation protocol for patient-derived xenografts of prostate cancer.
    Porter LH; Lawrence MG; Wang H; Clark AK; Bakshi A; Obinata D; Goode D; Papargiris M; Mural ; Clouston D; Ryan A; Norden S; Corey E; Nelson PS; Isaacs JT; Grummet J; Kourambas J; Sandhu S; Murphy DG; Pook D; Frydenberg M; Taylor RA; Risbridger GP
    Prostate; 2019 Aug; 79(11):1326-1337. PubMed ID: 31212368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
    Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
    Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of primary patient-derived xenografts of palliative TURP specimens to study castrate-resistant prostate cancer.
    Lawrence MG; Pook DW; Wang H; Porter LH; Frydenberg M; Kourambas J; Appu S; Poole C; Beardsley EK; Ryan A; Norden S; Papargiris MM; Risbridger GP; Taylor RA
    Prostate; 2015 Sep; 75(13):1475-83. PubMed ID: 26177841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biobanking of patient and patient-derived xenograft ovarian tumour tissue: efficient preservation with low and high fetal calf serum based methods.
    Alkema NG; Tomar T; Duiker EW; Jan Meersma G; Klip H; van der Zee AG; Wisman GB; de Jong S
    Sci Rep; 2015 Oct; 5():14495. PubMed ID: 26440065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of patient-derived xenografts in prostate cancer research.
    Lawrence MG; Taylor RA; Cuffe GB; Ang LS; Clark AK; Goode DL; Porter LH; Le Magnen C; Navone NM; Schalken JA; Wang Y; van Weerden WM; Corey E; Isaacs JT; Nelson PS; Risbridger GP
    Nat Rev Urol; 2023 Jun; 20(6):371-384. PubMed ID: 36650259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintaining viability and characteristics of cholangiocarcinoma tissue by vitrification-based cryopreservation.
    Zeng M; Yang QR; Fu GB; Zhang Y; Zhou X; Huang WJ; Zhang HD; Li WJ; Wang ZY; Yan HX; Zhai B
    Cryobiology; 2017 Oct; 78():41-46. PubMed ID: 28716599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An original patient-derived xenograft of prostate cancer with cyst formation.
    Yoshikawa T; Kobori G; Goto T; Akamatsu S; Terada N; Kobayashi T; Tanaka Y; Jung G; Kamba T; Ogawa O; Inoue T
    Prostate; 2016 Aug; 76(11):994-1003. PubMed ID: 27098584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-Derived Xenograft Models for Translational Prostate Cancer Research and Drug Development.
    Philp LK
    Methods Mol Biol; 2024; 2806():153-185. PubMed ID: 38676802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology.
    Risbridger GP; Clark AK; Porter LH; Toivanen R; Bakshi A; Lister NL; Pook D; Pezaro CJ; Sandhu S; Keerthikumar S; Quezada Urban R; Papargiris M; Kraska J; Madsen HB; Wang H; Richards MG; Niranjan B; O'Dea S; Teng L; Wheelahan W; Li Z; Choo N; Ouyang JF; Thorne H; Devereux L; Hicks RJ; Sengupta S; Harewood L; Iddawala M; Azad AA; Goad J; Grummet J; Kourambas J; Kwan EM; Moon D; Murphy DG; Pedersen J; Clouston D; Norden S; Ryan A; Furic L; Goode DL; Frydenberg M; Lawrence MG; Taylor RA
    Nat Commun; 2021 Aug; 12(1):5049. PubMed ID: 34413304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing prostate cancer patient derived xenografts: lessons learned from older studies.
    Russell PJ; Russell P; Rudduck C; Tse BW; Williams ED; Raghavan D
    Prostate; 2015 May; 75(6):628-36. PubMed ID: 25560784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a cryopreservation protocol for type A spermatogonia.
    Izadyar F; Matthijs-Rijsenbilt JJ; den Ouden K; Creemers LB; Woelders H; de Rooij DG
    J Androl; 2002; 23(4):537-45. PubMed ID: 12065461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease an--d Serve as Models for Evaluating Cancer Therapeutics.
    Nguyen HM; Vessella RL; Morrissey C; Brown LG; Coleman IM; Higano CS; Mostaghel EA; Zhang X; True LD; Lam HM; Roudier M; Lange PH; Nelson PS; Corey E
    Prostate; 2017 May; 77(6):654-671. PubMed ID: 28156002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction of Androgen Receptor Targeting shRNA Inhibits Tumor Growth in Patient-Derived Prostate Cancer Xenografts.
    Thomas PB; Alinezhad S; Joshi A; Sweeney K; Tse BWC; Tevz G; McPherson S; Nelson CC; Williams ED; Vela I
    Curr Oncol; 2023 Oct; 30(11):9437-9447. PubMed ID: 37999103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of Prostate Cancer Patient-Derived Xenografts to Investigate Mechanisms of Novel Treatments and Treatment Resistance.
    Lam HM; Nguyen HM; Corey E
    Methods Mol Biol; 2018; 1786():1-27. PubMed ID: 29786784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spheroid culture of LuCaP 136 patient-derived xenograft enables versatile preclinical models of prostate cancer.
    Valta MP; Zhao H; Saar M; Tuomela J; Nolley R; Linxweiler J; Sandholm J; Lehtimäki J; Härkönen P; Coleman I; Nelson PS; Corey E; Peehl DM
    Clin Exp Metastasis; 2016 Apr; 33(4):325-37. PubMed ID: 26873136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Patient Derived Xenograft Models of Overt Spontaneous Breast Cancer Metastasis: A Cautionary Note.
    Paez-Ribes M; Man S; Xu P; Kerbel RS
    PLoS One; 2016; 11(6):e0158034. PubMed ID: 27355476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian carcinoma patient derived xenografts reproduce their tumor of origin and preserve an oligoclonal structure.
    Colombo PE; du Manoir S; Orsett B; Bras-Gonçalves R; Lambros MB; MacKay A; Nguyen TT; Boissière F; Pourquier D; Bibeau F; Reis-Filho JS; Theillet C
    Oncotarget; 2015 Sep; 6(29):28327-40. PubMed ID: 26334103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of immediate cryopreservation on the establishment of patient derived xenografts from head and neck cancer patients.
    Abel L; Durmaz A; Hu R; Longhurst C; Baschnagel AM; Wheeler D; Scott JG; Kimple RJ
    J Transl Med; 2021 Apr; 19(1):180. PubMed ID: 33910584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xenografts of primary human prostatic carcinoma.
    Pretlow TG; Wolman SR; Micale MA; Pelley RJ; Kursh ED; Resnick MI; Bodner DR; Jacobberger JW; Delmoro CM; Giaconia JM
    J Natl Cancer Inst; 1993 Mar; 85(5):394-8. PubMed ID: 8433392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Freezing solution containing dimethylsulfoxide and fetal calf serum maintains survival and ultrastructure of goat preantral follicles after cryopreservation and in vitro culture of ovarian tissue.
    Castro SV; de Carvalho AA; da Silva CM; Faustino LR; Campello CC; Lucci CM; Báo SN; de Figueiredo JR; Rodrigues AP
    Cell Tissue Res; 2011 Nov; 346(2):283-92. PubMed ID: 22006251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.